GLOSSARY

Product-Level Regulation uses product effects on chemistry or regulation.

Flux control is usually distributed across steps, substrate supply and demand. Rate-limiting is condition-dependent rather than identifying an enzyme that always commands the whole pathway. A committed step marks more specific entry into a pathway and need not carry the greatest control. Increasing one enzyme or supplying its precursor does not guarantee greater network flux or performance without considering the wider system.

Allosteric regulation changes activity through communication between regulatory binding and functional regions; it can activate or inhibit. Feedback carries downstream-product or state information upstream, whereas feedforward conveys input or upstream information onward. Both can operate in one network. Regulation coordinates supply and use rather than keeping every enzyme maximally active, so more activation is not automatically a better nutritional or training outcome.

Adding or removing a chemical group can alter enzyme activity, location, stability or interactions. Phosphorylation is not universally activating; direction depends on protein and site. Acetylation, methylation and small-protein attachment have varied roles and are not all degradation labels. Post-translational changes must be distinguished from new protein production because their speed and persistence can differ, even when they influence the same pathway or exercise response.

For example, after training changes an enzyme result, first ask whether it was measured in blood, tissue or purified protein. Then assess assay conditions, nutrition and time since the last session alongside actual performance; this comparison helps distinguish a regulatory response from a nutritional deficiency or a presumed supplement need.

Enzyme abundance reflects protein synthesis and degradation; gene expression, RNA, protein quantity and measured activity are different layers. Induction and repression need definition because expression and activity can differ. Constitutive does not mean a perfectly constant amount under all conditions. In exercise interpretation, long-term capacity changes must be separated from rapid activation of existing enzyme and from actual pathway flux rather than treating them as interchangeable findings.

Measured activity is conversion per time under assay conditions rather than simply protein abundance. A substrate-rich assay may reveal potential capacity, while living tissue has different constraints and regulation. Units, tissue normalization and preparation methods are needed for comparison. Blood activity is not identical to intramuscular activity; laboratory changes require exercise timing, symptoms and tissue origin rather than being read as direct performance measures or a standalone diagnosis.

Training can change enzyme abundance, regulation or activity capacity depending on mode, intensity, volume and training history. An acute session response is not the same as chronic adaptation. Oxidative or glycolytic markers describe only part of performance; oxygen delivery, fuel stores and neural coordination also matter. Practical assessment therefore combines performance and recovery outcomes with adequate nutrition and the actual training program rather than relying on one enzyme marker.